Palatin Technologies Newsroom

Palatin Technologies: Positive Phase 2b Results and Strategic Growth Opportunities Justify Buy Rating

TipRanksDec 20, 2024 12:48 ET

Palatin Techs Analyst Ratings

BenzingaNov 25, 2024 11:25 ET

Palatin Technologies: Strategic Focus on Obesity and Diversified Pipeline Justifies Buy Rating

TipRanksNov 14, 2024 11:50 ET

Palatin Techs Analyst Ratings

BenzingaOct 24, 2024 06:32 ET

HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $17 Price Target

BenzingaOct 24, 2024 05:37 ET

Palatin Techs Analyst Ratings

BenzingaOct 1, 2024 12:05 ET

Buy Rating Affirmed: Palatin Technologies' Strong Earnings and Promising Pipeline Signal Growth Opportunities

TipRanksOct 1, 2024 11:57 ET

Palatin Techs Analyst Ratings

BenzingaAug 28, 2024 10:15 ET

Positive Buy Rating for Palatin Technologies Based on Promising Obesity and ED Clinical Trials

TipRanksAug 22, 2024 09:59 ET

Palatin Techs Analyst Ratings

BenzingaJun 20, 2024 11:28 ET

Palatin Techs Analyst Ratings

BenzingaJun 12, 2024 08:28 ET

Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN), Prestige Consumer Healthcare (PBH) and CervoMed (CRVO)

TipRanksMay 16, 2024 06:56 ET

Palatin Techs Analyst Ratings

BenzingaMay 15, 2024 14:02 ET

HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $17 Price Target

BenzingaMay 15, 2024 14:02 ET

Analysts Are Bullish on These Healthcare Stocks: AEON Biopharma (AEON), Palatin Technologies (PTN)

TipRanksMay 15, 2024 11:25 ET

HC Wainwright & Co. Reiterates Buy on Palatin Techs, Maintains $17 Price Target

BenzingaMay 8, 2024 15:30 ET

Palatin Techs Analyst Ratings

BenzingaMay 8, 2024 15:28 ET

Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Palatin Technologies (PTN)

TipRanksMay 8, 2024 12:25 ET

Palatin Techs Analyst Ratings

BenzingaMay 2, 2024 13:26 ET

Buy Rating Endorsed for Palatin Technologies Amidst Promising Obesity Treatment Advancements

TipRanksMay 2, 2024 11:30 ET